• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人与动物肠道共生菌和益生菌与生物安全的现代挑战:问题与展望。

Human and animal intestinal commensals and probiotics vs modern challenges of biosafety: problems and prospects.

机构信息

Kazan Institute of Biochemistry and Biophysics, FRC Kazan Scientific Center of RAS, Kazan, Russia.

Kazan Federal University, Kazan, Russia.

出版信息

Arch Razi Inst. 2024 Feb 1;79(1):28-32. doi: 10.32592/ARI.2024.79.1.28. eCollection 2024 Feb.

DOI:10.32592/ARI.2024.79.1.28
PMID:39192958
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11345466/
Abstract

The appearance of an array of data on the study of the intestinal microbiota in Metazoa has significantly expanded our understanding of the role of commensals in the control of a wide range of physiological functions in higher organisms in norm and pathology. In the intestine, where the microbial load significantly exceeds the number of microorganisms of other ecosystems, the components of the intestinal microbiota are a constant source of stimuli that induce activation of the host immune system. The introduction into practice of biomedical research of innovative high-resolution methods, including   multi-omics technologies, has brought data that change our understanding of intestinal commensals, including probiotics with GRAS status, widely used in medicine, agriculture and biotechnology. The ability of these bacteria to induce negative processes in the host body that are beneficial for bacterial proliferation and expansion revealed a clear lack of our knowledge about the logic of their life and the mechanisms of interaction with eukaryotic cells. This determines the urgent need for comprehensive research of probiotics and the development of standardization of their safety assessment. Apriori's confidence in the exceptional benefit of the bacteria widely used in medicine, agriculture and biotechnology has determined the seriously omission in our control system today - the lack of standardization of studies for the safety assessment of bacteria with GRAS status . The moment has come when it became clear that this gap should be promptly filled and that only exact understanding the molecular base of interacting the microbes with eukaryotic cells can provide the foundation for effective practical developments in controlling the evolution of bacterial virulence and probiotic safety strategy, as well as the competent use of genetic technologies for monitoring the environment and managing infectious processes, thus avoiding the dramatic consequences of large-scale interventions in the micro and macro worlds.

摘要

后生动物肠道微生物群研究中大量数据的出现,极大地扩展了我们对共生体在高等生物正常和病理生理功能控制中的作用的认识。在肠道中,微生物负荷远远超过其他生态系统中微生物的数量,肠道微生物群的组成是诱导宿主免疫系统激活的持续刺激源。创新性高分辨率方法(包括多组学技术)在生物医学研究中的应用,带来了改变我们对肠道共生体(包括具有 GRAS 地位的益生菌)认识的数据,这些益生菌广泛应用于医学、农业和生物技术。这些细菌在宿主体内诱导有利于细菌增殖和扩张的负面过程的能力,清楚地表明我们对其生活逻辑和与真核细胞相互作用的机制缺乏了解。这决定了全面研究益生菌和制定其安全性评估标准化的迫切需要。先前对广泛应用于医学、农业和生物技术的细菌的特殊益处的信心,决定了我们今天的控制系统中存在严重的疏忽——缺乏对具有 GRAS 地位的细菌的安全性评估研究的标准化。现在很明显,应该尽快填补这一空白,只有准确理解微生物与真核细胞相互作用的分子基础,才能为控制细菌毒力进化和益生菌安全策略的有效实际发展提供基础,以及为监测环境和管理传染病过程的遗传技术的熟练使用提供基础,从而避免在微观和宏观世界中进行大规模干预的戏剧性后果。

相似文献

1
Human and animal intestinal commensals and probiotics vs modern challenges of biosafety: problems and prospects.人与动物肠道共生菌和益生菌与生物安全的现代挑战:问题与展望。
Arch Razi Inst. 2024 Feb 1;79(1):28-32. doi: 10.32592/ARI.2024.79.1.28. eCollection 2024 Feb.
2
Tackling probiotic and gut microbiota functionality through proteomics.通过蛋白质组学研究益生菌和肠道微生物群的功能
J Proteomics. 2016 Sep 16;147:28-39. doi: 10.1016/j.jprot.2016.03.023. Epub 2016 Mar 18.
3
Immunological Tolerance and Function: Associations Between Intestinal Bacteria, Probiotics, Prebiotics, and Phages.免疫耐受与功能:肠道细菌、益生菌、益生元和噬菌体之间的关联。
Front Immunol. 2018 Oct 9;9:2240. doi: 10.3389/fimmu.2018.02240. eCollection 2018.
4
Probiotics, gut microbiota, and their influence on host health and disease.益生菌、肠道微生物群及其对宿主健康和疾病的影响。
Mol Nutr Food Res. 2017 Jan;61(1). doi: 10.1002/mnfr.201600240. Epub 2016 Oct 10.
5
Beneficial Effects of Probiotic Consumption on the Immune System.益生菌摄入对免疫系统的有益影响。
Ann Nutr Metab. 2019;74(2):115-124. doi: 10.1159/000496426. Epub 2019 Jan 23.
6
Probiotics, Photobiomodulation, and Disease Management: Controversies and Challenges.益生菌、光生物调节与疾病管理:争议与挑战。
Int J Mol Sci. 2021 May 6;22(9):4942. doi: 10.3390/ijms22094942.
7
Probiotics, prebiotics, and synbiotics regulate the intestinal microbiota differentially and restore the relative abundance of specific gut microorganisms.益生菌、益生元和合生菌通过调节肠道微生物群的差异,恢复特定肠道微生物的相对丰度。
J Dairy Sci. 2020 Jul;103(7):5816-5829. doi: 10.3168/jds.2019-18003. Epub 2020 May 14.
8
Food and gut originated bacteriocins involved in gut microbe-host interactions.食物和肠道来源的细菌素参与肠道微生物-宿主相互作用。
Crit Rev Microbiol. 2023 Aug;49(4):515-527. doi: 10.1080/1040841X.2022.2082860. Epub 2022 Jun 17.
9
The Future of Diabetes Management by Healthy Probiotic Microorganisms.健康益生菌对糖尿病管理的未来作用
Curr Diabetes Rev. 2017;13(6):582-589. doi: 10.2174/1573399812666161014112515.
10
Probiotics in digestive diseases: focus on Lactobacillus GG.消化系统疾病中的益生菌:聚焦于鼠李糖乳杆菌GG
Minerva Gastroenterol Dietol. 2015 Dec;61(4):273-92.

引用本文的文献

1
Probiotics under Selective Pressure: Novel Insights and Biosafety Challenge.处于选择性压力下的益生菌:新见解与生物安全挑战
Arch Razi Inst. 2024 Dec 31;79(6):1165-1182. doi: 10.32592/ARI.2024.79.6.1165. eCollection 2024 Dec.

本文引用的文献

1
Common pathogenic bacteria-induced reprogramming of the host proteinogenic amino acids metabolism.常见病原菌诱导的宿主蛋白氨基酸代谢重编程。
Amino Acids. 2023 Nov;55(11):1487-1499. doi: 10.1007/s00726-023-03334-w. Epub 2023 Oct 9.
2
Safety and efficacy of adding postbiotics in infant formula: a systematic review and meta-analysis.添加后生元于婴儿配方奶粉的安全性和有效性:系统评价和荟萃分析。
Pediatr Res. 2024 Jan;95(1):43-51. doi: 10.1038/s41390-023-02813-w. Epub 2023 Sep 12.
3
How Can the Microbiome Induce Carcinogenesis and Modulate Drug Resistance in Cancer Therapy?微生物组如何诱导癌症发生和调节癌症治疗中的药物耐药性?
Int J Mol Sci. 2023 Jul 24;24(14):11855. doi: 10.3390/ijms241411855.
4
Emerging role of bacterial outer membrane vesicle in gastrointestinal tract.细菌外膜囊泡在胃肠道中的新作用。
Gut Pathog. 2023 Apr 27;15(1):20. doi: 10.1186/s13099-023-00543-2.
5
Emerging issues in probiotic safety: 2023 perspectives.益生菌安全性的新问题:2023 年的观点。
Gut Microbes. 2023 Jan-Dec;15(1):2185034. doi: 10.1080/19490976.2023.2185034.
6
Role of Probiotics in Human Health.益生菌在人类健康中的作用。
Cureus. 2022 Nov 9;14(11):e31313. doi: 10.7759/cureus.31313. eCollection 2022 Nov.
7
A genetic approach to identify amino acids in Gcn1 required for Gcn2 activation.一种通过遗传方法鉴定 Gcn1 中 Gcn2 激活所需的氨基酸的方法。
PLoS One. 2022 Nov 28;17(11):e0277648. doi: 10.1371/journal.pone.0277648. eCollection 2022.
8
Modes of therapeutic delivery in synthetic microbiology.合成微生物学中的治疗传递模式。
Trends Microbiol. 2023 Feb;31(2):197-211. doi: 10.1016/j.tim.2022.09.003. Epub 2022 Oct 8.
9
Development of Resistance to Clarithromycin and Amoxicillin-Clavulanic Acid in Is Followed by Genomic Rearrangements and Evolution of Virulence.克拉霉素和阿莫西林克拉维酸耐药性的发展伴随着基因组重排和毒力的进化。
Microbiol Spectr. 2022 Jun 29;10(3):e0236021. doi: 10.1128/spectrum.02360-21. Epub 2022 May 17.
10
Ghost mitochondria drive metastasis through adaptive GCN2/Akt therapeutic vulnerability.幽灵线粒体通过适应性 GCN2/Akt 治疗脆弱性驱动转移。
Proc Natl Acad Sci U S A. 2022 Feb 22;119(8). doi: 10.1073/pnas.2115624119.